lifethreaten
pulmonari
influenza
caus
inborn
error
type
iii
ifn
immun
report
child
sever
pulmonari
influenza
yr
homozyg
lossoffunct
allel
cell
activ
gammaactiv
factor
gaf
homodim
ifnstimul
gene
factor
trimer
respons
transcriptom
induc
patient
cell
much
narrow
control
cell
howev
induct
subset
ifnstimul
gene
transcript
remain
detect
vitro
patient
cell
control
three
respiratori
virus
influenza
viru
iav
parainfluenza
viru
piv
respiratori
syncyti
viru
rsv
phenotyp
rescu
wildtyp
wherea
silenc
express
control
cell
increas
viral
replic
howev
child
control
variou
common
virus
vivo
includ
respiratori
virus
iav
find
show
human
type
iii
ifn
respons
pathway
essenti
control
iav
influenza
viru
common
pathogen
children
typic
caus
selflimit
respiratori
diseas
also
caus
sever
ill
pneumonia
acut
respiratori
distress
syndrom
ard
short
et
al
viru
strain
differ
influenc
frequenc
sever
infect
illustr
season
epidem
pandem
caus
new
recombin
influenza
virus
explain
interindividu
variabl
given
popul
infect
viru
moren
write
committe
consult
clinic
aspect
pandem
influenza
et
al
human
risk
factor
identifi
consist
mostli
acquir
comorbid
chronic
pulmonari
cardiovascular
diseas
old
age
pales
shaw
shieh
et
al
dawood
et
al
thu
pathogenesi
lifethreaten
pulmonari
influenza
individu
without
preexist
cardiac
pulmonari
diseas
remain
larg
unexplain
especi
children
center
diseas
control
prevent
recent
describ
autosom
recess
ar
complet
defici
first
genet
etiolog
lifethreaten
influenza
ard
otherwis
healthi
human
lack
type
type
iii
ifn
amplif
plasmacytoid
dendrit
cell
pdc
pulmonari
epitheli
cell
probabl
underli
patient
suscept
influenza
haploinsuffici
known
inborn
error
immun
underli
sever
influenza
albeit
patient
multipl
infect
three
patient
sever
influenza
age
yr
associ
abnorm
develop
multipl
myeloid
lymphoid
subset
includ
pdc
sologuren
et
al
influenza
first
sever
infect
one
patient
pasquet
et
al
soleviolan
et
al
mechan
underli
sever
influenza
patient
unknown
might
involv
lack
pdc
among
potent
type
type
iii
ifnproduc
cell
due
high
basal
express
coccia
et
al
asselinpaturel
et
al
osterlund
et
al
lauterbach
et
al
ning
et
al
intriguingli
inborn
error
product
ifn
shown
underli
sever
influenza
zhang
et
al
lamborn
et
al
interestingli
ifn
patient
defect
type
andor
iii
ifn
respons
report
suffer
sever
influenza
glocker
et
al
begu
et
al
boissondupui
et
al
hambleton
et
al
duncan
et
al
krein
et
al
shahni
et
al
eletto
et
al
moen
et
al
moreov
patient
known
inborn
error
immun
includ
patient
lack
cell
b
cell
report
suffer
sever
influenza
picard
et
al
collect
data
suggest
human
product
type
andor
type
iii
ifn
essenti
protect
immun
influenza
viru
mice
either
homozyg
allel
heterozyg
allel
also
character
although
mice
found
possess
significantli
reduc
pdc
count
studi
infecti
diseas
research
instead
focus
hematopoiet
vascular
integr
johnson
et
al
collin
et
al
onodera
et
al
similarli
integr
function
type
iii
ifn
signal
pathway
remain
larg
unexplor
mice
mice
display
reduc
induct
follow
either
viral
infect
stimul
synthet
tlr
agonist
well
increas
vulner
infect
encephalomyocard
viru
sato
et
al
honda
et
al
recent
identifi
one
differenti
express
gene
mice
infect
influenza
viru
iav
overlap
differenti
express
gene
identifi
sirna
screen
import
iav
replic
wilk
et
al
furthermor
mice
deriv
background
contain
function
allel
infect
influenza
viru
experienc
greater
morbid
mortal
control
mice
wilk
et
al
studi
analyz
genet
immunolog
influenza
infect
also
perform
mice
thu
reexamin
mice
express
due
crucial
role
ifnstimul
gene
isg
product
mous
immun
influenza
viru
staeh
et
al
iwasaki
pillai
ciancanelli
et
al
significantli
howev
mice
substanti
sensit
iav
even
background
koerner
et
al
similar
studi
background
demonstr
crucial
role
ifn
signal
defens
influenza
infect
koerner
et
al
kaminski
et
al
mice
impair
type
iii
ifn
immun
shown
display
margin
elev
influenza
viru
replic
rel
wt
mice
hypersensit
influenza
viru
type
ifn
signal
also
ablat
mordstein
et
al
overal
type
andor
type
iii
ifn
immun
seem
crucial
protect
immun
influenza
viru
human
mice
inborn
error
human
type
iii
ifn
immun
howev
underli
sever
influenza
least
among
human
patient
report
therefor
hypothes
defect
type
iii
ifn
defici
may
underli
sever
influenza
individu
thu
set
analyz
wholeexom
sequenc
we
data
children
sever
influenza
first
focus
type
iii
ifnrel
gene
homozygos
splice
site
mutat
studi
girl
patient
p
born
firstcousin
algerian
parent
live
franc
hospit
sever
infect
iav
requir
mechan
ventil
tamiflu
treatment
histori
recurr
benign
bronchiol
biliari
perfor
follow
measlesmumpsrubella
mmr
vaccin
yr
age
recurr
fever
without
caus
pathogen
identifi
fig
p
also
infect
respiratori
syncyti
viru
rsv
within
first
year
life
hospit
admit
intens
care
unit
icu
character
p
histori
viral
infect
age
yr
wk
igg
iv
substitut
matern
antibodi
disappear
virscan
xu
et
al
detect
signific
specif
antibodi
p
serum
mani
virus
includ
human
cytomegaloviru
human
rhinoviru
hrv
enteroviru
addit
confirm
infect
rsv
iav
fig
recoveri
iav
infect
experienc
adenoviru
parainfluenza
viru
piv
infect
also
confirm
virscan
admit
hospit
infect
neither
requir
admiss
icu
perform
we
kindr
trio
design
identifi
mutat
encod
critic
element
type
iii
ifn
signal
pathway
confirm
sanger
sequenc
fig
b
fu
et
al
veal
et
al
kimura
et
al
p
homozyg
mutat
parent
healthi
sister
heterozyg
famili
segreg
consist
ar
pattern
inherit
complet
penetr
casanova
et
al
variat
absent
public
databas
includ
genom
bravo
genom
aggreg
databas
gnomad
databas
encompass
exom
aggreg
consortium
exac
databas
mutat
occur
final
nucleotid
exon
predict
disrupt
essenti
splice
site
boundari
exon
intron
well
produc
aspart
acid
asparagin
mutat
amino
acid
differ
predict
mutat
protein
structur
present
refer
allel
effect
cdna
combin
annotationdepend
deplet
cadd
score
variant
high
mutat
signific
cutoff
fig
c
figur
privat
variant
alter
mrna
splice
child
sever
influenza
pneumon
pedigre
famili
doubl
line
connect
parent
indic
consanguin
proband
indic
arrow
fill
shape
indic
affect
individu
open
shape
identifi
unaffect
individu
b
chromatogram
demonstr
mutat
patient
pbmcderiv
dna
red
arrow
c
popul
genet
homozyg
code
missens
predict
lossoffunct
mutat
taken
gnomad
inhous
cohort
patient
variant
privat
shown
red
two
variant
shown
blue
also
identifi
cohort
schemat
illustr
gene
exon
number
region
correspond
function
signific
domain
color
brown
dnabind
domain
dbd
gray
nuclear
local
sequenc
nl
purpl
iad
patient
mutat
indic
red
mutat
indic
blue
e
transcript
left
panel
rel
frequenc
right
panel
produc
exon
trap
cell
result
repres
two
independ
experi
f
cdna
sequenc
detect
splice
mrna
cell
number
total
abnorm
clone
sequenc
indic
result
repres
two
experi
figur
impact
ifn
receptorproxim
signal
qrtpcr
measur
mrna
level
pbmc
patient
mother
healthi
control
two
probeson
probe
span
intron
second
probe
span
intron
repres
result
four
independ
experi
shown
b
top
wb
endogen
patient
cell
gap
dh
use
load
control
bottom
stat
phosphostat
pstat
level
also
assess
follow
stimul
uml
either
h
cell
two
healthi
control
patient
mother
patient
patient
ifn
patient
ifn
patient
repres
result
five
independ
experi
shown
c
wb
cell
stabli
transfect
indic
variant
green
variant
report
lossoffunct
vitro
assay
blue
variant
found
inhous
red
patient
gap
dh
use
load
control
repres
result
four
independ
experi
shown
wb
patient
cell
stabli
transfect
indic
variant
gap
dh
use
load
control
repres
result
four
independ
experi
shown
e
wb
analysi
local
cell
two
healthi
control
patient
mother
patient
patient
ifn
patient
ifn
patient
gap
dh
laminac
use
load
control
repres
result
three
independ
experi
shown
f
report
assay
isr
gasdepend
firefli
luciferas
test
cell
stimul
uml
either
h
stabli
transfect
indic
variant
green
variant
report
lossoffunct
vitro
assay
blue
variant
found
inhous
red
patient
specif
respons
ifn
stimul
calcul
ratio
suggest
deleteri
kircher
et
al
itan
et
al
final
p
exom
show
homozygos
consist
parent
first
cousin
belkadi
et
al
consist
homozyg
nonsynonym
rare
variat
minor
allel
frequenc
also
found
gene
none
known
diseasecaus
gene
gene
encod
topoisomeras
exoribonucleas
two
connect
known
primari
immunodefici
pid
gene
connectom
analysi
carri
variant
missens
itan
et
al
three
gene
carri
homozyg
variat
predict
lossoffunct
unrel
pid
dishevel
bind
antagonist
catenin
enth
domain
contain
ent
forssman
glycolipid
synthaselik
protein
overal
data
suggest
p
ar
defici
homozygos
plausibl
genotyp
respons
sever
influenza
popul
genet
human
encompass
exon
includ
eight
proteincod
exon
exon
fig
although
gene
damag
index
moder
mcdonaldkreitman
neutral
index
indic
neg
select
consist
one
nonsynonym
exon
two
intron
variant
found
homozygos
gnomad
includ
wholeexom
wholegenom
sequenc
c
p
g
minor
allel
frequenc
respect
three
variant
present
inhous
we
cohort
patient
sever
infecti
diseas
two
intron
variant
found
heterozyg
state
multipl
individu
variant
found
homozyg
state
one
individu
one
three
variant
predict
alter
protein
sequenc
may
therefor
impact
function
latter
two
mutat
occur
intron
predict
creat
splice
site
actual
creat
splice
site
data
shown
allel
exist
cohort
homozyg
state
individu
suffer
nonvir
infect
brain
furthermor
analysi
inhous
we
cohort
reveal
third
homozyg
nonsynonym
variat
found
public
databas
fig
c
individu
harbor
variant
also
possess
homozyg
mutat
underli
chronic
autoinflamm
invas
bacteri
infect
muscular
amylopectinosi
also
experienc
profound
human
cytomegaloviru
viremia
homozygos
three
exon
nonsynonym
variant
predict
affect
individu
common
sever
influenza
cadd
score
three
variant
mutat
signific
cutoff
indic
may
impact
function
fig
c
itan
et
al
therefor
set
assess
consequ
p
variant
function
well
two
missens
allel
found
homozygos
rare
individu
gener
popul
inhous
cohort
express
truncat
mrna
protein
mutant
allel
mutat
occur
essenti
splice
site
termin
nucleotid
exon
hypothes
would
produc
aberrantli
splice
transcript
thu
transient
transfect
segment
p
allel
encompass
intron
well
segment
ident
region
wt
allel
fibrosarcoma
cell
gift
pellegrini
institut
pasteur
cytokin
signal
unit
in
erm
pari
franc
fig
john
et
al
sequenc
result
cdna
reveal
two
transcript
produc
p
allel
fig
e
domin
transcript
exhibit
absenc
exon
normal
exon
second
minor
transcript
also
lack
exon
use
altern
splice
acceptor
site
exon
segment
wt
allel
howev
produc
four
differ
transcript
one
transcript
demonstr
correct
splice
exon
junction
second
transcript
lack
exon
correctli
use
splice
site
exon
domin
product
two
rare
transcript
also
observ
one
product
altern
splice
acceptor
site
intron
wherea
anoth
result
altern
splice
acceptor
site
exon
fig
e
correctli
splice
transcript
observ
healthi
control
blcl
ebvtransform
b
lymphoblastoid
cell
line
larg
antigen
immort
fibroblast
cell
suggest
two
altern
transcript
observ
overexpress
set
present
endogen
moreov
cdna
sequenc
p
blcl
cell
reveal
transcript
would
result
variant
protein
transcript
lack
exon
fig
f
mutant
transcript
correspond
allel
thu
hereaft
refer
delet
infram
introduc
prematur
stop
codon
next
evalu
express
p
peripher
blood
mononuclear
cell
pbmc
cell
consist
result
cdna
sequenc
transcript
lack
exon
detect
p
pbmc
reduc
number
fulllength
transcript
detect
individu
harbor
mutat
proport
dosag
allel
fig
western
blot
wb
polyclon
antibodi
detect
truncat
speci
p
cell
mother
wherea
fulllength
detect
p
cell
fig
b
molecular
weight
truncat
protein
roughli
kd
lower
wt
consist
lack
exon
amino
acid
form
substanti
portion
firefli
luciferas
report
gene
activ
constitut
express
renilla
luciferas
activ
rlu
rel
luciferas
ratio
repres
result
three
independ
experi
shown
g
emsa
analysi
isr
ga
bind
ifnstimul
blcl
three
healthi
control
patient
mother
patient
patient
patient
repres
result
three
independ
experi
shown
irf
associ
domain
iad
stat
protein
interact
fig
overal
find
show
patient
ar
defici
studi
function
mutat
protein
first
focus
proxim
signal
event
ifn
respons
pathway
assess
express
p
mrna
plasmid
encod
two
missens
mrna
found
homozygos
individu
wt
first
stabli
transfect
cell
express
verifi
wb
fig
c
allel
includ
throughout
studi
sinc
report
lossoffunct
vitro
studi
due
impair
interact
ifn
impair
isg
upregul
tang
et
al
allel
express
compar
level
indic
variant
normal
transcrib
translat
encod
mrna
protein
stabl
condit
fig
c
found
phosphoryl
normal
cell
transfect
allel
follow
stimul
type
ifn
shown
stabl
transfect
wt
p
cell
restor
normal
express
suggest
poor
express
cell
due
homozyg
mutat
fig
normal
phosphoryl
p
cell
immedi
follow
stimul
type
ifn
suggest
dispens
process
fig
b
data
consist
previou
report
find
phosphoryl
occur
immedi
follow
ifn
stimul
cell
jaworska
et
al
arimoto
et
al
thu
allel
produc
truncat
protein
affect
ifn
arproxim
signal
term
phosphoryl
least
fibroblast
fibrosarcoma
cell
particip
format
transcript
factor
bind
via
iad
also
enabl
bind
trimer
dna
transloc
nucleu
veal
et
al
darnel
et
al
taniguchi
et
al
stark
darnel
p
protein
delet
occur
iad
region
fig
hypothes
may
unabl
engag
form
function
consist
recent
report
domain
function
rengachari
et
al
test
first
fraction
nuclear
cytoplasm
compart
p
basal
condit
determin
local
p
protein
fig
e
consist
presenc
nuclear
local
sequenc
nterminu
small
amount
visibl
nucleu
even
basal
condit
although
express
substanti
lower
level
fulllength
protein
also
visibl
nucleu
consist
cell
transfect
exhibit
abolish
luciferas
transcript
luciferas
product
driven
ifnstimul
respons
element
isr
promot
normal
transcript
activ
driven
gamma
activ
sequenc
ga
promot
fig
f
contrast
wt
variant
abl
induc
transcript
luciferas
isr
ga
promot
variant
display
intermedi
phenotyp
roughli
activ
compar
wt
allel
suggest
hypomorph
taken
togeth
data
strongli
suggest
p
variant
unabl
encod
protein
form
function
transcript
factor
hypomorph
neutral
electrophoret
mobil
shift
assay
emsa
confirm
p
cell
abl
form
function
complex
follow
stimul
evidenc
abolish
isr
bind
vitro
although
cell
abl
form
gammaactiv
factor
complex
bind
ga
element
condit
fig
g
patient
therefor
like
homozyg
null
allel
transcript
detect
cell
test
howev
one
exclud
remot
possibl
splice
defect
leaki
untest
cell
residu
express
might
result
sever
complet
form
defici
due
inabl
p
cell
form
function
hypothes
cell
would
display
profound
inabl
upregul
isg
follow
ifn
stimul
contrast
control
cell
p
blcl
substanti
upregul
express
respons
type
ifn
assess
quantit
rtpcr
qrtpcr
wb
fig
ad
stabl
transfect
p
cell
wt
abl
rescu
impair
induct
isg
fig
e
similarli
cell
stabli
transfect
abl
induc
transcript
either
classic
isg
compar
wt
fig
f
express
use
throughout
qrtpcr
experi
demonstr
abil
cell
respond
type
ii
ifn
howev
respons
type
ifn
substanti
broader
four
five
gene
potenti
hundr
gene
display
alter
express
level
mostafavi
et
al
character
fulli
transcript
respons
p
cell
type
ifn
perform
mrna
sequenc
mrnaseq
time
point
gap
dh
use
load
control
repres
result
three
independ
experi
shown
transcript
level
assess
qrtpcr
blcl
cell
treat
uml
h
cell
three
healthi
control
patient
mother
ifn
ifn
patient
repres
result
four
independ
experi
shown
e
transcript
level
assess
qrtpcr
cell
healthi
control
p
mother
p
stabli
transfect
luciferas
control
luc
indic
variant
wt
wt
green
report
lossoffunct
variant
blue
variant
found
inhous
red
patient
variant
cell
stimul
uml
h
repres
result
four
independ
experi
shown
f
similar
e
qrtpcr
analysi
express
parent
cell
cell
cell
stimul
uml
h
repres
result
three
independ
experi
shown
analysi
p
blcl
cell
primari
fibroblast
follow
vitro
stimul
p
blcl
cell
fig
b
dg
primari
fibroblast
fig
c
eg
demonstr
inabl
regul
broad
array
gene
includ
isg
also
neg
regul
transcript
data
shown
howev
respons
p
cell
abolish
altogeth
inde
transcript
pass
filter
criteria
p
blcl
cell
primari
fibroblast
transcript
respect
also
found
regul
ifn
interferom
databas
fig
c
furthermor
mani
upregul
isg
significantli
less
induc
isg
healthi
control
cell
fig
e
f
interestingli
howev
isg
actual
induc
higher
level
cell
compar
healthi
control
fig
e
f
furthermor
differ
necessarili
due
reduct
basal
transcript
level
sinc
gene
highli
induc
cell
roughli
exhibit
higher
absolut
transcript
level
cell
data
shown
dissect
isg
network
dysregul
p
blcl
cell
select
subset
transcript
strongli
induc
greater
fivefold
linear
scale
among
healthi
control
subject
studi
transcript
found
induc
nonrespons
p
blcl
cell
transcript
queri
isg
interferom
databas
use
cutoff
differenti
ifnrespons
nonrespons
gene
respons
nonrespons
transcript
p
cell
transcript
respect
identifi
isg
interferom
databas
use
isg
respons
network
analysi
use
geneman
ia
fig
g
notabl
isg
induc
p
cell
includ
gene
encod
ifit
famili
protein
compon
isgyl
system
consist
presenc
transcript
factor
phosphoryl
homodim
downstream
ifn
receptor
howev
mrna
import
isg
guanylatebind
protein
induc
p
cell
albeit
gene
lower
level
compar
control
subject
type
iii
ifn
respons
pathway
easili
studi
blcl
krein
et
al
collect
studi
indic
p
cell
express
lossoffunct
allel
sever
narrow
transcript
respons
type
ifn
multipl
cell
type
function
gammaactiv
factor
lack
complex
result
induct
small
subset
isg
investig
impact
defici
cellintrins
nonhematopoiet
immun
use
p
cell
observ
differ
iav
titer
h
infect
compar
healthi
control
p
heterozyg
mother
fig
pretreat
substanti
reduc
viral
replic
healthi
control
cell
p
cell
produc
roughli
higher
iav
titer
cell
intact
ifn
signal
pathway
fig
similarli
p
substanti
suscept
vesicular
stomat
viru
vsv
h
infect
absenc
pretreat
time
point
beyond
h
cell
pretreat
ifn
roughli
differ
titer
healthi
control
p
fig
b
demonstr
defect
iav
vsv
immun
depend
stabli
transfect
p
cell
variou
allel
empti
vector
analyz
abil
transfect
cell
control
vsv
iav
infect
fig
c
express
wt
abl
rescu
inabl
p
cell
control
infect
either
pathogen
express
allel
unabl
significantli
cell
express
mutat
also
abl
control
infect
vsv
iav
suggest
allel
may
deleteri
context
type
ifn
signal
antivir
immun
consist
lack
overt
viral
infect
experienc
individu
harbor
mutat
allel
also
somewhat
abl
control
infect
vsv
iav
although
level
wt
allel
suggest
partial
form
defici
may
contribut
viral
infect
patient
show
cellintrins
antivir
immun
broadli
impair
test
piv
rsv
fig
eh
demonstr
mediat
suscept
viral
infect
vitro
also
knock
mitochondri
antivir
signal
protein
mav
express
primari
dermal
fibroblast
fc
valu
isg
found
differenti
regul
three
control
subject
rel
unstimul
cell
bar
graph
c
quantifi
number
isg
differenti
regul
compar
unstimul
cell
healthi
control
patient
e
shown
fold
chang
valu
subset
isg
found
induc
linear
scale
blcl
cell
upper
panel
primari
fibroblast
lower
panel
patient
upon
vitro
stimul
select
subset
isg
gene
healthi
control
identifi
mrnaseq
analysi
use
patient
gene
first
pass
filter
queri
gene
identifi
interferom
databas
retain
gene
respons
vitro
ifn
stimul
isg
fail
induc
least
linear
scale
patient
cell
exclud
retain
isg
stratifi
three
group
less
less
similar
higher
induc
gene
rel
averag
respons
healthi
control
subject
number
gene
group
shown
bracket
signific
differ
p
kruskalw
test
f
fc
induc
isg
blcl
upper
panel
primari
fibroblast
lower
panel
correspond
valu
healthi
donor
g
network
analysi
subset
highli
induc
fivefold
linear
scale
isg
among
control
subject
blcl
respons
patient
biolog
pathway
physic
interact
depict
blue
red
line
respect
fc
use
cutoff
distinguish
respons
red
circl
nonrespons
blue
circl
isg
highli
induc
isg
use
queri
shade
yellow
healthi
individu
use
sirna
transfect
cell
nontarget
sirna
sineg
instead
fig
knockdown
either
mav
result
increas
viral
transcript
compar
sineg
cell
upon
infect
hrv
suggest
nonredund
immun
positivesens
rna
virus
addit
negativesens
virus
alreadi
test
similarli
knockdown
increas
number
infect
cell
rel
number
viral
transcript
produc
similar
extent
mav
knockdown
compar
sineg
cell
rsv
piv
fig
cf
collect
data
indic
defici
lead
broad
defect
cellintrins
immun
virus
vitro
altogeth
data
strongli
suggest
inherit
defici
underli
p
impair
immun
influenza
infect
subsequ
hospit
ard
herein
describ
ar
complet
defici
child
lifethreaten
influenza
data
establish
causal
relationship
defici
patient
sever
pulmonari
influenza
casanova
et
al
follow
autosom
domin
defici
ar
defici
ar
defici
third
describ
singlegen
inborn
error
immun
underli
lifethreaten
influenza
pneumon
casanova
b
ciancanelli
et
al
contrast
defici
disrupt
amplif
antivir
ifn
especi
pdc
cell
express
high
constitut
level
defici
result
inabl
cell
type
respond
fulli
effect
type
ifn
infer
type
iii
ifn
mechanist
connect
defici
human
suggest
type
iii
ifn
respons
driven
amplif
mediat
signal
essenti
defens
influenza
viru
howev
patient
defect
type
andor
iii
ifn
signal
pathway
includ
defici
ifn
report
suffer
sever
influenza
boissondupui
et
al
hambleton
et
al
engelhardt
grimbach
duncan
et
al
krein
et
al
shahni
et
al
eletto
et
al
moen
et
al
perhap
die
sever
infect
exposur
influenza
viru
viru
control
independ
signal
protein
least
type
ifn
signal
without
protein
de
weerd
et
al
defect
partial
oppos
complet
due
hypomorph
natur
mutant
allel
chapgier
et
al
hambleton
et
al
duncan
et
al
altern
unlik
five
gene
might
regul
transcript
key
subset
isg
specif
mediat
immun
influenza
viru
follow
type
iii
ifn
stimul
patient
ifn
defici
recent
report
yet
addit
defect
ifn
prevent
conclus
drawn
mechan
infecti
phenotyp
hoyosbachiloglu
et
al
clearer
pictur
contribut
gene
human
protect
immun
influenza
viru
emerg
inborn
error
discov
patient
diagnos
significantli
patient
hospit
icu
follow
infect
rsv
hrv
confirm
serolog
virscan
indic
defici
may
result
extens
suscept
pulmonari
viral
infect
contrast
child
prone
sever
recurr
rhinoviru
infect
lamborn
et
al
children
prone
rsv
sever
viral
infect
respiratori
tract
influenza
asgari
et
al
zaki
et
al
human
thu
seem
control
differ
set
respiratori
virus
vivo
interestingli
defici
may
also
result
narrow
infecti
phenotyp
report
case
human
uniqu
suscept
influenza
infect
last
followup
age
yr
without
prophylaxi
annual
influenza
vaccin
unpublish
data
defici
result
slightli
broader
infecti
phenotyp
includ
infect
influenza
viru
like
mmr
vaccinestrain
viru
phenotyp
might
broader
patient
start
igg
iv
yr
age
howev
defici
clinic
closer
defici
compar
defici
inde
known
patient
latter
defect
suffer
mani
sever
infect
includ
mycobacteri
infect
papilloma
viru
infect
blastomycosi
repeat
viral
infect
respiratori
tract
collin
et
al
sever
influenza
present
featur
one
patient
quickli
thereaft
display
phenotyp
infecti
otherwis
sologuren
et
al
broad
infecti
phenotyp
consist
broad
immunolog
phenotyp
defici
restrict
lack
develop
type
iii
ifnproduc
pdc
reserv
list
strike
defici
underli
narrow
rang
sever
infect
almost
limit
sever
influenza
pneumon
significantli
singl
case
defici
report
thu
far
studi
need
comprehens
defin
viral
suscept
result
defici
determin
extent
type
iii
ifn
immun
redund
protect
immun
viral
infect
suggest
factor
may
compens
defici
pathway
among
patient
defect
type
andor
iii
ifn
signal
pathway
complic
mmr
vaccin
report
patient
ifn
biallel
mutat
hambleton
et
al
duncan
et
al
burn
et
al
moen
et
al
although
rel
rare
individu
vaccinestrain
mmr
infect
report
individu
ar
complet
defici
vaccin
unclear
whether
patient
ifn
defici
complet
partial
defici
hambleton
et
al
duncan
et
al
moen
et
al
interestingli
mmr
vaccin
complic
observ
patient
ar
partial
defici
report
patient
partial
complet
defici
vaccin
boissondupui
et
al
krein
et
al
eletto
et
al
suggest
possibl
diverg
mice
dispens
protect
measl
viru
hahm
et
al
odonnel
et
al
parsimoni
theori
explain
observ
mediat
physiolog
relev
branch
type
iii
ifn
signal
pathway
mice
independ
subset
branch
depend
signal
human
complex
describ
mice
human
unclear
could
drive
cellular
chang
requir
defens
viral
infect
lou
et
al
abdulsat
et
al
note
mrnaseq
analysi
observ
upregul
p
primari
fibroblast
blcl
respons
stimul
vitro
perhap
coincident
consist
nonredund
role
immun
measl
infect
hambleton
et
al
result
add
evid
mice
differ
compon
complex
regul
distinct
nonredund
subset
isg
addit
jointli
regul
core
gene
altern
differ
mmr
phenotyp
patient
variou
inborn
error
type
iii
ifn
immun
may
mere
reflect
impact
modifi
environ
includ
mmr
inoculum
ultim
experi
natur
deciph
report
reveal
nonredund
role
human
type
andor
iii
ifn
signal
pathway
cellintrins
immun
influenza
viru
probabl
also
mmr
vaccin
patient
whole
blood
serum
skin
biopsi
obtain
patient
rel
paid
healthi
volunt
individu
gave
written
inform
consent
particip
research
protocol
approv
institut
review
board
rockefel
univers
nation
institut
allergi
infecti
diseas
nation
institut
health
report
case
girl
born
consanguin
parent
first
cousin
f
algerian
descent
live
franc
admit
intens
care
acut
respiratori
distress
secondari
infect
iav
age
mo
accord
medic
histori
born
wk
gestat
birth
weight
g
height
cm
apgar
score
famili
histori
neg
previou
sever
infecti
diseas
sinc
age
mo
patient
histori
recurr
fever
dmo
associ
digest
featur
includ
diarrhea
abdomin
pain
without
vomit
transient
cutan
rash
intermitt
urticaria
initi
suggest
autoinflammatori
syndrom
sinc
infecti
agent
identifi
prior
support
treatment
posit
respect
pgml
pgml
wherea
normal
neg
mefv
mvk
tra
ps
sequenc
found
without
deleteri
variat
anti
antibodi
consist
posit
sequenc
dna
normal
experienc
five
episod
bronchiol
reveal
sever
asthma
prescrib
montelukast
albuterol
ipratropium
bromid
gingivostomat
aden
four
episod
prolong
gastroenter
hospit
pediatr
icu
picu
due
idiopath
biliari
perfor
mmr
vaccin
mo
old
dissemin
intravascular
coagul
suspect
secondari
thrombopenia
low
prothrombin
time
associ
elev
liver
enzym
sgot
uil
sgpt
uil
readmit
picu
mo
later
suspicion
septic
shock
absenc
detect
pathogen
associ
elev
creactiv
protein
mgl
lymphopenia
low
platelet
count
low
prothrombin
time
mo
age
admit
picu
sever
influenza
infect
result
ard
requir
mechan
ventil
increas
oxygen
requir
continu
posit
airway
pressur
fio
intub
develop
sever
ard
bilater
infiltr
chest
radiographi
place
mechan
ventil
volum
support
mode
frequenc
per
minut
fio
bacteriolog
viral
sputum
cultur
neg
except
iav
administ
salbutamol
ipratropium
bromid
ketamin
theophyllin
magnesium
sulfat
ceftriaxon
oseltamivir
oseltamivir
treatment
stop
third
day
bilater
parotidi
cervic
aden
appear
treat
amoxicillin
clavulan
acid
discharg
picu
condit
improv
enough
discharg
hospit
standard
immunolog
test
perform
serum
level
igg
iga
igm
unremark
natur
killer
lymphocyt
count
conserv
wherea
modest
b
lymphocytosi
measur
tabl
lymphocyt
prolifer
normal
pha
tuberculin
candidin
n
low
presenc
tetanu
cmv
hsv
antigen
n
tabl
b
cell
count
within
normal
rang
patient
igg
seroposit
tetanu
diphtheria
haemophilu
measl
mump
rubella
hbv
ag
hb
neg
antihb
posit
antihbc
neg
follow
routin
vaccin
remain
seroneg
hav
hcv
vzv
parvoviru
ebv
cmv
pneumococcu
despit
proper
vaccin
latter
intraven
ig
wk
begun
yr
mo
age
recurr
viral
infect
result
improv
recurr
fever
profil
digest
symptom
suscept
viral
infect
sinc
iv
ig
start
patient
hospit
two
occas
acut
respiratori
distress
secondari
metapneumoviru
febril
pseudoocclus
syndrom
free
fluid
morrisson
pouch
detect
sonogram
secondari
symptom
gastroenter
time
rna
parainfluenza
group
detect
pcr
sputum
pathogen
detect
known
caus
gastroenter
also
neg
rhinovirusenteroviru
metapneumoviru
influenza
b
coronaviru
rsv
b
pcr
sputum
adenoviru
noroviru
enteroviru
rotaviru
pcr
stool
neither
episod
admit
picu
exom
captur
perform
sureselect
human
exon
mb
kit
agil
technolog
pairedend
sequenc
perform
hiseq
illumina
gener
read
align
sequenc
refer
build
human
genom
use
bwa
align
downstream
process
variant
call
perform
genom
analysi
toolkit
samtool
picard
mckenna
et
al
substitut
indel
call
made
gatk
unifi
genotyp
variant
annot
use
annot
softwar
system
develop
inhous
ng
henikoff
adzhubei
et
al
kircher
et
al
genet
we
analysi
patient
reveal
total
variant
p
filter
variat
found
databas
gnomad
databas
exom
infecti
diseas
influenza
frequenc
leav
nonsynonym
code
variant
patient
exom
homozyg
heterozyg
tabl
heterozyg
variant
inherit
one
parent
consid
model
complet
penetr
except
four
heterozyg
two
homozyg
variant
none
variant
affect
gene
relat
immun
mutat
allel
found
genom
dna
sampl
ethnic
group
includ
french
hgdpceph
human
divers
panel
missens
mutat
cadd
score
genom
measur
individu
homozygos
plot
p
two
european
individu
consanguin
famili
individu
nonconsanguin
famili
inhous
we
databas
homozygos
comput
proport
autosom
genom
belong
run
homozygos
roh
roh
defin
rang
least
mb
length
contain
least
singl
nucleotid
polymorph
snp
estim
use
homozyg
option
pli
nk
softwar
purcel
et
al
centromer
exclud
long
genom
stretch
devoid
snp
inclus
might
inflat
estim
homozygos
flank
snp
homozyg
length
autosom
genom
fix
kb
previous
describ
mcquillan
et
al
estim
select
pressur
act
indic
purifi
select
estim
neutral
index
stoletzki
eyrewalk
popul
level
pnp
dnd
pn
ps
number
nonsynonym
synonym
allel
respect
popul
level
genom
project
dn
ds
number
nonsynonym
synonym
fix
site
respect
code
sequenc
pbmc
isol
ficollpaqu
densiti
gradient
lymphoprep
proteogenix
blood
patient
mother
healthi
donor
dermal
fibroblast
madindarbi
canin
kidney
vero
cell
maintain
dmem
supplement
fb
blcl
grown
rpmi
medium
supplement
fb
stabli
transfect
dermal
fibroblast
obtain
transfect
ptri
use
lipofectamin
invitrogen
accord
manufactur
protocol
stabl
transfect
select
puromycin
treatment
subsequ
fluorescenceactiv
cell
sort
rfpexpress
cell
yield
rfp
fibroblast
cdna
clone
pgemt
clone
vector
promega
sitedirect
mutagenesi
perform
obtain
indic
mutant
construct
construct
subclon
ptripcmvivsbirestagrfpdest
vector
use
gateway
clone
technolog
life
technolog
resequenc
ensur
advantiti
mutat
gener
clone
fibroblast
pretreat
schere
imukin
boehring
ingelheim
specifi
time
lysi
cell
lyse
lysi
buffer
mm
nacl
mm
tri
ph
mm
edta
mm
egta
glycerol
supplement
mm
dithiothreitol
phosstop
roch
complet
proteas
inhibitor
cocktail
roch
protein
lysat
per
lane
resolv
sdspage
transfer
polyvinyliden
fluorid
membran
probe
unconjug
primari
antibodi
hrpconjug
secondari
antibodi
antigap
dh
santa
cruz
biotechnolog
antilamin
ac
santa
cruz
biotechnolog
antibodi
use
load
control
probe
antibodi
recogn
cterminu
dilut
santa
cruz
biotechnolog
supersign
west
pico
chemiluminesc
substrat
thermo
fisher
scientif
use
visual
hrp
activ
signal
detect
amersham
imag
ge
life
scienc
knockdown
effici
determin
immunoblot
total
protein
load
per
lane
separ
nupag
bistri
sdspage
gel
invitrogen
transfer
onto
nitrocellulos
membran
use
transblot
turbo
transfer
system
biorad
laboratori
block
nonfat
dri
milk
biorad
laboratori
pb
contain
tween
sigmaaldrich
membran
blot
antibodi
mav
clone
cell
signal
technolog
clone
bd
bioscienc
follow
incub
appropri
hrpconjug
secondari
antibodi
jackson
immunoresearch
laboratori
supersign
west
pico
chemiluminesc
substrat
supersign
west
dura
extend
durat
substrat
thermo
fisher
scientif
signal
detect
chemidoctm
touch
imag
system
biorad
laboratori
emsa
perform
previous
describ
chapgier
et
al
brief
cell
activ
block
incub
cold
pb
cell
gentli
lyse
remov
cytoplasm
protein
keep
nucleu
intact
nuclear
lysi
buffer
ad
recov
nuclear
extract
subject
nondenatur
electrophoresi
alexa
ga
promot
tat
ttc
cca
isr
promot
cgg
gaa
agg
gaa
acc
gaa
act
probe
gel
imag
amersham
imag
ge
life
scienc
channel
report
assay
cell
transfect
indic
express
plasmid
firefli
luciferas
plasmid
control
isr
ga
promot
constitut
express
renilla
firefli
luciferas
plasmid
normal
h
transfect
cell
stimul
h
left
unstimul
luciferas
level
measur
use
dualglo
reagent
accord
manufactur
protocol
promega
firefli
luciferas
valu
normal
renilla
luciferas
valu
fold
induct
express
rel
unstimul
sampl
exon
trap
assay
cell
transfect
plasmid
contain
genom
region
encompass
exon
wt
mutat
rna
purifi
cell
splice
product
amplifi
use
flank
hivtat
sequenc
vector
rna
reversetranscrib
ligat
pgemt
vector
promega
cell
thermo
fischer
scientif
transform
result
plasmid
coloni
pcr
follow
sequenc
perform
determin
splice
product
produc
mutat
wt
allel
qrtpcr
total
rna
pbmc
extract
use
rnaqueousmicro
kit
ambio
revers
transcript
perform
use
highcapac
cdna
revers
transcript
kit
appli
biosystem
messeng
rna
quantifi
probe
exon
exon
thermo
fischer
scientif
qrtpcr
use
taqman
gene
express
assay
appli
biosystem
normal
express
level
rna
isol
blcl
cell
stimul
iuml
h
rna
lysi
buffer
treat
dnase
purifi
accord
manufactur
protocol
zymo
research
rtpcr
perform
use
random
hexam
superscript
iii
revers
strand
synthesi
kit
accord
manufactur
instruct
thermo
fisher
scientif
quantit
realtim
pcr
perform
appli
biosystem
taqman
assay
use
housekeep
gene
normal
result
express
use
method
describ
manufactur
viru
assay
iav
vsv
infect
fibroblast
infect
influenza
viru
multipl
infect
moi
moi
inoculum
absorb
onto
cell
min
cell
wash
twice
hank
balanc
salt
solut
cultur
presenc
tpcktreat
trypsin
sigmaaldrich
viru
sampl
collect
indic
time
infect
influenza
titer
determin
plaqu
assay
madindarbi
canin
kidney
cell
fibroblast
infect
vsv
moi
inoculum
absorb
onto
cell
min
wash
twice
pb
cultur
dmem
fb
viru
sampl
collect
indic
time
point
viral
titer
determin
endpoint
dilut
vero
cell
use
reed
muench
calcul
indic
cell
pretreat
h
viru
infect
recombin
rsv
deriv
strain
contain
enhanc
gfp
use
previous
describ
lamborn
et
al
recombin
human
piv
type
deriv
js
strain
contain
enhanc
gfp
gift
dr
p
collin
nation
institut
allergi
infecti
diseas
zhang
et
al
fibroblast
seed
cell
per
well
tissu
cultur
plate
dmem
supplement
fb
mm
lglutamin
uml
penicillin
streptomycin
invitrogen
sigmaaldrich
overnight
cultur
cell
infect
rsvgfp
moi
moi
h
infect
cell
harvest
flow
cytometr
detect
gfp
rsvinfect
viabl
cell
perform
previous
describ
lamborn
et
al
flow
cytometr
detect
gfp
viabl
cell
perform
similar
condit
sirna
knockdown
experi
human
primari
dermal
fibroblast
transfect
neg
sirna
control
stealth
sirna
thermo
fisher
scientif
sirna
mav
thermo
fisher
scientif
use
primari
cell
nucleofector
kit
lonza
describ
lamborn
et
al
transfect
cell
infect
rsv
moi
piv
moi
moi
rsv
piv
hrv
replic
quantit
describ
patient
serum
analyz
virscan
two
independ
experi
previous
describ
xu
et
al
briefli
oligonucleotid
librari
encod
amino
acid
peptid
tile
across
genom
viral
speci
synthes
releas
dna
microarray
clone
phage
patient
serum
contain
igg
ad
phage
librari
immunoprecipit
perform
protein
g
bead
enrich
peptid
identifi
pcr
illumina
sequenc
peptid
cassett
immunoprecipit
phage
viral
replic
prism
softwar
graphpad
use
calcul
p
valu
use
oneway
ano
va
dunnett
multipl
comparison
kruskalw
test
dunn
multipl
comparison
total
rna
blcl
primari
fibroblast
cell
isol
rneasi
kit
qia
gen
rna
integr
assess
agil
bioanalyz
agil
technolog
poli
mrna
enrich
cdna
librari
prepar
perform
use
truseq
strand
mrna
librari
prep
kit
illumina
accord
manufactur
recommend
pairedend
sequenc
perform
illumina
cycl
qualiti
control
raw
fastq
file
perform
use
fastqc
andrew
sampl
align
refer
genom
ensembl
use
star
align
dobin
et
al
align
output
convert
bam
file
use
samtool
result
bam
file
use
quantifi
read
count
use
htseqcount
tool
ander
et
al
output
technic
repeat
patient
sampl
stimul
duplic
found
high
correl
coeffici
shown
subsequ
downstream
analysi
perform
r
statist
program
languag
team
read
count
technic
repeat
averag
transcript
identifi
compar
stimul
unstimul
condit
three
healthi
control
subject
use
minim
chang
express
upregul
downregul
cutoff
respons
gene
list
satisfi
filter
criteria
three
control
result
total
gene
respons
blcl
primari
fibroblast
respect
gene
list
use
identifi
use
chang
cutoff
unrespons
gene
cell
patient
overal
residu
respons
patient
cell
comput
count
respons
gene
patient
cell
type
calcul
percentag
total
number
respons
gene
cell
type
respons
healthi
control
subject
set
use
ms
excel
filter
respons
gene
common
uniqu
specif
patient
subsequ
analysi
blcl
network
analysi
greater
fivefold
cutoff
appli
control
group
gener
target
list
gene
upregul
gene
healthi
control
induc
fivefold
gene
use
filter
patient
use
cutoff
appli
rnaseq
analysi
patient
total
gene
found
induc
nonrespons
two
list
enter
interferom
queri
isg
use
similar
experiment
criteria
current
studi
rusinova
et
al
gene
found
respons
patient
identifi
isg
nonrespons
gene
identifi
isg
combin
isg
gene
list
patient
use
conduct
network
analysi
geneman
ia
use
biolog
process
base
gene
ontolog
weight
method
maximum
result
gene
set
wardefarley
et
al
network
examin
use
biolog
pathway
physic
interact
data
avail
mrnaseq
data
deposit
geo
avail
access
onlin
supplement
materi
fig
show
antibodi
virus
detect
virscan
analysi
patient
sera
fig
display
pcr
scheme
use
exon
trap
experi
tabl
present
immunophenotyp
result
patient
tabl
demonstr
prolifer
patient
cell
respons
variou
stimuli
tabl
catalog
rare
biallel
mutat
present
patient
